# A Study to Investigate the Safety and Efficacy of UC-MSCs in Pediatric Patients With Cerebral Palsy

> **NCT04873752** · PHASE1,PHASE2 · COMPLETED · sponsor: **Rohto Pharmaceutical Co., Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Cerebral Palsy
- Periventricular Leukomalacia

## Interventions

- **BIOLOGICAL:** UDI-001

## Key facts

- **NCT ID:** NCT04873752
- **Lead sponsor:** Rohto Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-02
- **Primary completion:** 2023-07-12
- **Final completion:** 2024-02-15
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04873752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04873752, "A Study to Investigate the Safety and Efficacy of UC-MSCs in Pediatric Patients With Cerebral Palsy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04873752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*